The estimated Net Worth of Todd Berard is at least $4.66 Milhão dollars as of 14 June 2024. Mr Berard owns over 10,000 units of Biolife Solutions Inc stock worth over $2,525,252 and over the last 10 years he sold BLFS stock worth over $1,846,662. In addition, he makes $286,490 as Chief Marketing Officer at Biolife Solutions Inc.
Mr has made over 68 trades of the Biolife Solutions Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of BLFS stock worth $201,800 on 14 June 2024.
The largest trade he's ever made was exercising 32,136 units of Biolife Solutions Inc stock on 12 April 2022 worth over $745,234. On average, Mr trades about 4,193 units every 27 days since 2015. As of 14 June 2024 he still owns at least 108,894 units of Biolife Solutions Inc stock.
You can see the complete history of Mr Berard stock trades at the bottom of the page.
Todd Berard is the Chief Marketing Officer at Biolife Solutions Inc.
As the Chief Marketing Officer of Biolife Solutions Inc, the total compensation of Mr Berard at Biolife Solutions Inc is $286,490. There are 8 executives at Biolife Solutions Inc getting paid more, with Michael Rice having the highest compensation of $2,241,770.
Mr Berard is 52, he's been the Chief Marketing Officer of Biolife Solutions Inc since . There are 10 older and 7 younger executives at Biolife Solutions Inc. The oldest executive at Biolife Solutions Inc is Thomas Girschweiler, 61, who is the Director.
Todd's mailing address filed with the SEC is 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Over the last 22 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler, eWalter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Biolife Solutions Inc executives and other stock owners filed with the SEC include: